We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Proteome Sciences Plc | LSE:PRM | London | Ordinary Share | GB0003104196 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.65 | 2.30 | 3.00 | - | 0.00 | 13:55:29 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 5.03M | -2.44M | -0.0083 | -3.19 | 7.82M |
Date | Subject | Author | Discuss |
---|---|---|---|
07/6/2024 18:09 | Keep an eye on Bird flu, don't know if PRM has anything in that line | goggin | |
06/6/2024 10:46 | Mystified by today's trades, at least as reported here! | small crow | |
06/6/2024 08:08 | wasjobber, Yes, I've heard the same thing. TMTpro 32plex(+) hyperplexing should bring all the main mass spec manufacturers into the fold. | pools2 | |
06/6/2024 07:47 | Waters mass spec 32-plex TMTpro rumours! | wasjobber | |
05/6/2024 16:10 | Single run multiomics is now a reality with TMTpro 32plex reagents | pools2 | |
05/6/2024 15:29 | TMTPro 32 plex from Thermo Fisher Scientific Vice President Research and Development presentation at ASMS 2024 this week. | colinhy | |
04/6/2024 08:30 | ASMS 2024 Conference - 3rd June 2024 Customers will soon experience the power of higher multiplexing with the launch of the Thermo Scientific TMTpro 32plex Label Reagents, enabling the analysis of up to 32 samples in a single LC-MS injection. This higher level of multiplexing is particularly beneficial for applications requiring higher throughput and depth of coverage such as chemoproteomics, peptidomics, and single-cell proteomics. | pools2 | |
31/5/2024 08:52 | I see personal medicine started its journey in the uk today and where were this shower,nowhere as usual.!!! | peverill | |
23/5/2024 08:15 | 1st May 2024 Rise of Automation in Mass Spectrometry–B "Sample multiplexing, via techniques such as isobaric labeling with tandem mass tags (TMTs), has emerged as a pivotal technique in MS-based proteomics ............." | pools2 | |
22/5/2024 15:33 | What has it to do with Northants James. Are the team being stroke tested? Or perhaps they are testing them for 'mad cow disease' or more likely 'mad goat disease'? | dominiccummings | |
22/5/2024 11:36 | I can say with 100% certainty,they weren't mentioned,and no I didn't watch it. | peverill | |
22/5/2024 08:28 | Mixed emotions for head coach Sadler as Northants are denied by Derbyshire By Jeremy Casey Published 21st May 2024, 07:14 BST John Sadler admitted to a sense of dejection but also pride in his team's performance as Northants were denied a first Vitality County Championship Division Two victory of the season on a dramatic final day against Derbyshire on Monday. Facing a victory target of 371 after Emilio Gay, with a stunning 153 not out from 161 balls, and Karun Nair (55) had powered the County to a morning declaration on 301 for three, the home side dug in to rally brilliantly from sliding to 149 for seven at tea. From looking as if they were heading for certain defeat, they held out for the next 41 overs to finish on 261 for nine and seal the draw, with Zak Chappell going on the offensive to hit 72 from 101 balls, and Anuj Dal blocking his way to 31 not out from 131 balls. Two late wickets did give Northants hope, and in the final over of the day Daj did nick a Ben Sanderson delivery, but the ball flew agonosingly between a gap in the six-strong slip cordon and the game was up. For Northants, Rob Keogh starred with the ball, claiming five for 62 to add to his first innings century, while loan man Liam Patterson-White took three for 58 from 29 overs. | barry evans | |
22/5/2024 08:26 | 10/05/2024 12:00 PRBB Auditorium PRBB-CRG Sessions Steven Gygi Harvard Medical School "Proteomics as a biological assay" Host: Eduard Sabido Abstract:Proteomics is the systematic analysis of proteins for their various properties including expression levels, modification state, structure, interaction partners, function, and many more. For protein expression profiling, the combination of mass spectrometry with sample multiplexing creates a unique biological assay where replicates, positive and negative controls, as well as all treatment conditions can be measured in a single experiment. Tandem mass tags (TMT) facilitate these analyses and will soon be available as a 32plex reagent set. In this talk, I will highlight several new advances with these reagents including their use in targeted proteomics assays. As an example, we created an assay to measure short-lived proteins and applied it to 4 human cell lines. We identified ~1000 proteins with targeted degradation resulting in half-lives of only a few hours--often in a cell-line specific manner. | pools2 | |
21/5/2024 16:17 | I received an email this morning from Amati (fund managers-small companies fund & Aim VCT fund ) inviting me to join a live meeting this morning -the topic being Proteomics.Unfortuna | base7 | |
17/5/2024 18:30 | But you let CJP and squad do it for 20 years and lap it up.They did it again yesterday,how long before enough is enough.?? | peverill | |
17/5/2024 18:16 | Where's the fun in that?? | peverill | |
17/5/2024 16:22 | #92948, Is he talking about me? Bar Room Monkeys: 1 Brains as Big as Brazil: 0 | jeffian | |
17/5/2024 15:50 | #92950 You don’t have to. It is your choice. | monte1 | |
17/5/2024 15:27 | Not really theirs alone - we have to put up with their whining day after day. | small crow | |
17/5/2024 15:23 | I think that is their business, isn’t it? | barry evans | |
17/5/2024 15:18 | If someone's not happy, and they don't see any prospects, why don't they sell??? | small crow | |
17/5/2024 12:55 | Let's be honest,they didn't have a clue when anything was due for release or even if it would be released.A complete rabble,everything they ever licensed has been shelved.Galaxy the same and a Director of said company sat there,not a clue.Richard!!!!!wha | peverill | |
17/5/2024 11:03 | I think the outcome would have been the same for me. I've never won anything on the horses! | jeffian |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions